119 related articles for article (PubMed ID: 35810606)
21. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
[TBL] [Abstract][Full Text] [Related]
22. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents.
Nordstrom BL; Mines D; Gu Y; Mercaldi C; Aquino P; Harrison MJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1357-64. PubMed ID: 22511558
[TBL] [Abstract][Full Text] [Related]
23. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
24. Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.
Fazeli Farsani S; Souverein PC; Overbeek JA; van der Vorst MM; Knibbe CA; Herings RM; de Boer A; Mantel-Teeuwisse AK
Br J Clin Pharmacol; 2015 Aug; 80(2):294-303. PubMed ID: 25683632
[TBL] [Abstract][Full Text] [Related]
25. Infections in patients with multiple sclerosis: A national cohort study in Sweden.
Castelo-Branco A; Chiesa F; Conte S; Bengtsson C; Lee S; Minton N; Niemcryk S; Lindholm A; Rosenlund M; Piehl F; Montgomery S
Mult Scler Relat Disord; 2020 Oct; 45():102420. PubMed ID: 32736217
[TBL] [Abstract][Full Text] [Related]
26. Cancer risk among patients with multiple sclerosis: a population-based register study.
Nielsen NM; Rostgaard K; Rasmussen S; Koch-Henriksen N; Storm HH; Melbye M; Hjalgrim H
Int J Cancer; 2006 Feb; 118(4):979-84. PubMed ID: 16152598
[TBL] [Abstract][Full Text] [Related]
27. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
28. Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis.
Cook S; Leist T; Comi G; Montalban X; Giovannoni G; Nolting A; Hicking C; Galazka A; Sylvester E
Mult Scler Relat Disord; 2019 Apr; 29():157-167. PubMed ID: 30885374
[TBL] [Abstract][Full Text] [Related]
29. Cancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burden.
Seo GH; Kim MJ; Seo S; Hwang B; Lee E; Yun Y; Choi M; Kim M; Kim JW; Kim ES; Kim HB; Song KH
Medicine (Baltimore); 2016 Sep; 95(38):e4919. PubMed ID: 27661041
[TBL] [Abstract][Full Text] [Related]
30. Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
Rugbjerg K; Friis S; Lassen CF; Ritz B; Olsen JH
Int J Cancer; 2012 Oct; 131(8):1904-11. PubMed ID: 22278152
[TBL] [Abstract][Full Text] [Related]
31. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
32. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
33. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
34. Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents.
Mariottini A; Forci B; Gualdani E; Romoli M; Repice AM; Barilaro A; Mechi C; Massacesi L; Francesconi P
Mult Scler Relat Disord; 2022 Apr; 60():103679. PubMed ID: 35217486
[TBL] [Abstract][Full Text] [Related]
35. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study.
Kroon JS; Wohlfarth TD; Dieleman J; Sutterland AL; Storosum JG; Denys D; de Haan L; Sturkenboom MC
Bipolar Disord; 2013 May; 15(3):306-13. PubMed ID: 23531096
[TBL] [Abstract][Full Text] [Related]
36. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs.
Cho SK; Lee J; Han M; Bae SC; Sung YK
Arthritis Res Ther; 2017 Dec; 19(1):277. PubMed ID: 29246243
[TBL] [Abstract][Full Text] [Related]
37. Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Tseng CC; Chang SJ; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Yen JH
Prev Med; 2016 Mar; 84():6-11. PubMed ID: 26724518
[TBL] [Abstract][Full Text] [Related]
38. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
O'Connell K; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
[TBL] [Abstract][Full Text] [Related]
39. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.
Man A; Zhu Y; Zhang Y; Dubreuil M; Rho YH; Peloquin C; Simms RW; Choi HK
Ann Rheum Dis; 2013 Jul; 72(7):1188-93. PubMed ID: 22904260
[TBL] [Abstract][Full Text] [Related]
40. Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study.
Grytten N; Myhr KM; Celius EG; Benjaminsen E; Kampman MT; Midgard R; Vatne A; Aarseth JH; Riise T; Torkildsen Ø
Mult Scler Relat Disord; 2021 Oct; 55():103209. PubMed ID: 34419754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
